Impact of CYP2C19 Metabolizer Status on Intragastric Acid Suppression During Administration of Generic Omeprazole and Esomeprazole – A Randomized, Two-Way Crossover Study

2011 ◽  
Vol 140 (5) ◽  
pp. S-730
Author(s):  
Stephan Miehlke ◽  
Susanne Loebe ◽  
Ahmed Madisch ◽  
Eberhard Kuhlisch ◽  
Martin W. Laass ◽  
...  
Keyword(s):  
Crossover Study ◽  
Acid Suppression ◽  
Intragastric Acid

Intragastric acid suppression and pharmacokinetics of twice-daily esomeprazole: a randomized, three-way crossover study

2004 ◽  
Vol 20 (4) ◽  
pp. 399-406 ◽  
Author(s):  
P. O. Katz ◽  
D. O. Castell ◽  
Y. Chen ◽  
T. Andersson ◽  
M. B. Sostek
Keyword(s):  
Crossover Study ◽  
Acid Suppression ◽  
Intragastric Acid

Cest ostemes of H. pylori treatment for patients on chronic acid suppression

2001 ◽  
Vol 120 (5) ◽  
pp. A120-A120
Author(s):  
D KEAMEY ◽  
C LIU ◽  
C CRUMP
Keyword(s):  
Acid Suppression ◽  
H Pylori

PPIs Can Cause ‘Addiction’ to Acid Suppression

2010 ◽  
Vol 43 (11) ◽  
pp. 15
Author(s):  
CAROLINE HELWICK
Keyword(s):  
Acid Suppression

PPI Acid Suppression–Fracture Link Reinforced

2011 ◽  
Vol 12 (11) ◽  
pp. 15
Author(s):  
CAROLINE HELWICK
Keyword(s):  
Acid Suppression

Inhibition of Spontaneous Platelet Aggregation by Sulfinpyrazone

1979 ◽  
Vol 42 (02) ◽  
pp. 621-625 ◽  
Author(s):  
G G Nenci ◽  
G Agnelli ◽  
M Berrettini ◽  
P Parise ◽  
E Ballatori
Keyword(s):  
Platelet Aggregation ◽  
Crossover Study ◽  
Double Blind ◽  
Platelet Aggregability ◽  
Initiation Of Therapy ◽  
Spontaneous Platelet Aggregation ◽  
Blind Crossover Study ◽  
Double Blind Crossover Study

SummaryIn a randomized double-blind crossover study in 16 patients with enhanced in vitro spontaneous platelet aggregation, sulfinpyrazone proved to be effective in normalizing platelet aggregability within 4 days after initiation of therapy.

Sign in / Sign up

Export Citation Format

Share Document